PRICE T ROWE ASSOCIATES INC /MD/
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 80255
BALTIMORE, MD
Position in RXRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,721,490
+$22,656 QoQ
Shares Held
560,746
+35.0% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. RXRX ranks #144 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in RXRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,721,490 | 560,746 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,698,834 | 415,363 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,556,153 | 318,884 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,425,235 | 281,667 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,186,197 | 224,234 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $892,252 | 131,990 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $740,966 | 112,438 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $660,862 | 88,115 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $618,788 | 62,065 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $557,721 | 56,564 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $405,258 | 52,975 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $573,890 | 76,826 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $498,869 | 74,793 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $585,335 | 75,919 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $385,231 | 36,206 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $185,592 | 22,800 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,025,280 | 562,190 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $14,690,225 | 857,573 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $13,361,216 | 580,670 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $21,282,602 | 583,085 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||